Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of torcetrapib + atorvastatin versus atorvastatin alone for major cardiovascular events
2004-000156-16Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronary arteriosclerosis comparing Torcetrapib + atorvastatin with Atorvastatin alone (2 arms). Started Aug 2004; status: terminated.
02
Drugs
rocacetrapibatorvastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2004-000156-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000156-16.